Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000023393 | SCV000791898 | likely pathogenic | Agenesis of the corpus callosum with peripheral neuropathy | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000023393 | SCV002572422 | pathogenic | Agenesis of the corpus callosum with peripheral neuropathy | 2022-08-29 | criteria provided, single submitter | clinical testing | Variant summary: SLC12A6 c.3400C>T (p.Arg1134X), located in the last exon (exon 25) results in a premature termination codon predicted to cause a truncation of the last 17 amino acid residues at the C-terminal end of the encoded protein. The variant allele was found at a frequency of 8e-06 in 250814 control chromosomes. c.3400C>T has been reported in the literature as a homozygous genotype in two individuals from one family affected with features of Hereditary motor and sensory neuropathy with agenesis of the corpus callosum (Andermann Syndrome) (example, Salin-Cantegrel_2011). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function demonstrating a loss of interaction with CK-B, the braintype creatine kinase (CK-B), which is an ATP-generating protein and a potent activator of SLC12A6 (KCC3) via a direct interaction with the carboxyl-terminal domain of the co-transporter (Salin-Cantegrel_2011). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Baylor Genetics | RCV000023393 | SCV004201193 | pathogenic | Agenesis of the corpus callosum with peripheral neuropathy | 2022-07-22 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000023393 | SCV000044684 | pathogenic | Agenesis of the corpus callosum with peripheral neuropathy | 2011-08-12 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium | RCV000790222 | SCV000929614 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |